Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up

A long-term follow-up (LTFU) of the nine-valent human papillomavirus (9vHPV) vaccine efficacy study in young women aged 16–26 years was initiated to evaluate if vaccine effectiveness for up to 14 years post-vaccination will remain above 90%. Vaccine effectiveness is measured as percent reduction in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjaer, Susanne K., Nygård, Mari, Sundström, Karin, Munk, Christian, Berger, Sophie, Dzabic, Mensur, Fridrich, Katrin Elisabeth, Waldstrøm, Marianne, Sørbye, Sveinung Wergeland, Bautista, Oliver, Group, Thomas, Luxembourg, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018381/
https://www.ncbi.nlm.nih.gov/pubmed/33326342
http://dx.doi.org/10.1080/21645515.2020.1839292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018381/
https://www.ncbi.nlm.nih.gov/pubmed/33326342
http://dx.doi.org/10.1080/21645515.2020.1839292

Ejemplares similares